These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8559151)

  • 21. Cloning of cDNAs encoding the variable domains of antibody BrE-3 and construction of a chimeric antibody.
    Couto JR; Blank EW; Peterson JA; Ceriani RL
    Hybridoma; 1993 Feb; 12(1):15-23. PubMed ID: 8454302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The monoclonal antibody, 7E3 and treatment of coronary artery disease.
    Talley JD
    J Ark Med Soc; 1996 Feb; 92(9):453-4. PubMed ID: 8742163
    [No Abstract]   [Full Text] [Related]  

  • 23. Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: implications for inhibition of the internal pool of GPIIb/IIIa receptors.
    Kleiman NS; Raizner AE; Jordan R; Wang AL; Norton D; Mace KF; Joshi A; Coller BS; Weisman HF
    J Am Coll Cardiol; 1995 Dec; 26(7):1665-71. PubMed ID: 7594101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombocytopenia after treatment with platelet glycoprotein IIb/IIIa inhibitors.
    Abrams CS; Cines DB
    Curr Hematol Rep; 2004 Mar; 3(2):143-7. PubMed ID: 14965491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 7E3 F(ab')2, an effective antagonist of rat alphaIIbbeta3 and alphavbeta3, blocks in vivo thrombus formation and in vitro angiogenesis.
    Sassoli PM; Emmell EL; Tam SH; Trikha M; Zhou Z; Jordan RE; Nakada MT
    Thromb Haemost; 2001 May; 85(5):896-902. PubMed ID: 11372685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis.
    Trikha M; Zhou Z; Timar J; Raso E; Kennel M; Emmell E; Nakada MT
    Cancer Res; 2002 May; 62(10):2824-33. PubMed ID: 12019160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrin beta3 regions controlling binding of murine mAb 7E3: implications for the mechanism of integrin alphaIIbbeta3 activation.
    Artoni A; Li J; Mitchell B; Ruan J; Takagi J; Springer TA; French DL; Coller BS
    Proc Natl Acad Sci U S A; 2004 Sep; 101(36):13114-20. PubMed ID: 15277669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiographic evaluation of middle cerebral artery reperfusion caused by platelet glycoprotein IIb/IIIa receptor complex antagonist murine 7E3 F(ab')2 in a model of focal cerebral ischemia in rats.
    Yang Y; Li Q; Nakada MT; Yang T; Shuaib A
    J Neurosurg; 2001 Apr; 94(4):582-8. PubMed ID: 11302656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycoprotein IIb/IIIa antagonist, murine 7E3 F(ab') 2, and tissue plasminogen activator in focal ischemia: evaluation of efficacy and risk of hemorrhage with combination therapy.
    Shuaib A; Yang Y; Nakada MT; Li Q; Yang T
    J Cereb Blood Flow Metab; 2002 Feb; 22(2):215-22. PubMed ID: 11823719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex.
    Coller BS
    J Clin Invest; 1985 Jul; 76(1):101-8. PubMed ID: 2991335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and characterization of chimeric anti-carcinoembryonic antigen monoclonal antibodies and their Fab fragments.
    Kamigaki T; Ohyanagi H; Yamamoto M; Kaneda T; Goto T; Ohmura T; Yokoyama K; Saitoh Y
    Jpn J Cancer Res; 1994 Mar; 85(3):298-305. PubMed ID: 8188529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular identification of the cross-reacting epitope on alphaM beta2 integrin I domain recognized by anti-alphaIIb beta3 monoclonal antibody 7E3 and its involvement in leukocyte adherence.
    Plescia J; Conte MS; VanMeter G; Ambrosini G; Altieri DC
    J Biol Chem; 1998 Aug; 273(32):20372-7. PubMed ID: 9685389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiplatelet antibody [7E3 F(ab')2] prevents rethrombosis after recombinant tissue-type plasminogen activator-induced coronary artery thrombolysis in a canine model.
    Mickelson JK; Simpson PJ; Cronin M; Homeister JW; Laywell E; Kitzen J; Lucchesi BR
    Circulation; 1990 Feb; 81(2):617-27. PubMed ID: 2105175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antithrombotic assessment of the effects of combination therapy with the anticoagulants efegatran and heparin and the glycoprotein IIb-IIIa platelet receptor antagonist 7E3 in a canine model of coronary artery thrombosis.
    Shetler TJ; Crowe VG; Bailey BD; Jackson CV
    Circulation; 1996 Oct; 94(7):1719-25. PubMed ID: 8840866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and functional characterization of a murine/human chimeric antibody with specificity for the human interleukin-2 receptor.
    Vandevyver C; Steukers M; Lambrechts J; Heyligen H; Raus J
    Mol Immunol; 1993 Jul; 30(10):865-76. PubMed ID: 8341281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cloning of cDNAs encoding the variable domains of antibody KC4G3 and construction of a chimeric antibody.
    Couto JR; Blank EW; Peterson JA; Ceriani RL
    Hybridoma; 1993 Aug; 12(4):485-9. PubMed ID: 8244420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chimerization of LL2, a rapidly internalizing antibody specific for B cell lymphoma.
    Leung SO; Shevitz J; Pellegrini MC; Dion AS; Shih LB; Goldenberg DM; Hansen HJ
    Hybridoma; 1994 Dec; 13(6):469-76. PubMed ID: 7737671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MHC class II-independent, Vbeta-specific activation of T cells by superantigen mutants fused to anti-tumor Fab fragments: implications for use in treatment of human colon carcinoma.
    Newton DW; Dohlsten M; Lando PA; Kalland T; Olsson C; Kotb M
    Int J Mol Med; 1998 Jan; 1(1):157-62. PubMed ID: 9852214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chimeric 7E3 Fab (ReoPro) decreases detectable CD11b on neutrophils from patients undergoing coronary angioplasty.
    Mickelson JK; Ali MN; Kleiman NS; Lakkis NM; Chow TW; Hughes BJ; Smith CW
    J Am Coll Cardiol; 1999 Jan; 33(1):97-106. PubMed ID: 9935015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.